http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112522394-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112522394-B |
titleOfInvention | Novel exosome release-related targets and their applications in monitoring and suppressing tumors |
abstract | The present invention provides a novel exosome release-related target and its application in monitoring and suppressing tumors. The present invention discloses exosomes produced by senescent cells and some biomolecules involved in regulating the exosomes, which are closely related to drug resistance and tumor prognosis after tumor chemotherapy treatment. Therefore, the present invention provides a new target for tumor suppression and reversal of tumor drug resistance, and a new marker for tumor diagnosis and prognosis evaluation. |
priorityDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 265.